Medlive Technology Co., Ltd. — Governance Information 2023

Mar 23, 2023

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [119 x 52] intentionally omitted <==

Medlive Technology Co., Ltd. 醫脈通科技有限公司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 2192)

PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION

AND

ADOPTION OF THE NEW MEMORANDUM AND ARTICLES OF ASSOCIATION

This announcement is made by Medlive Technology Co., Ltd. (the “ Company ”) pursuant to Rule 13.51(1) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the “ Listing Rules ”).

The board of directors (the “ Board ”) of the Company proposed to (i) make certain amendments (the “ Proposed Amendments ”) to the existing memorandum of association and articles of association of the Company, for the purpose of, among others, (a) reflecting the core shareholder protection standards as set out in the revised Appendix 3 to the Listing Rules which took effect on 1 January 2022, (b) bringing the articles of association of the Company in line with amendments made to the Listing Rules and the applicable law and procedures in the Cayman Islands, and (c) incorporating certain housekeeping changes; and (ii) adopt the new memorandum of association and articles of association of the Company incorporating and consolidating all the Proposed Amendments (the “ New Memorandum and Articles of Association ”).

– 1 –

The proposed adoption of the New Memorandum and Articles of Association is subject to approval by shareholders of the Company by way of special resolution at the annual general meeting of the Company to be held on 9 June 2023 (or any adjourned meeting), and will become effective upon the approval by the shareholders of the Company at the annual general meeting. A circular of the Company containing, among others, detailed information of the Proposed Amendments as well as the adoption of the New Memorandum and Articles of Association will be despatched to the shareholders of the Company as soon as practicable.

By order of the Board Medlive Technology Co., Ltd. Tian Liping Chairwoman and Chief Executive Officer

Hong Kong, 23 March 2023

As at the date of this announcement, the Board comprises Ms. Tian Liping, Mr. Tian Lixin, Mr. Tian Lijun and Ms. Zhou Xin as executive Directors; Mr. Eiji Tsuchiya and Dr. Li Zhuolin as non-executive Directors; and Mr. Richard Yeh, Dr. Ma Jun and Ms. Wang Shan as independent non-executive Directors.

– 2 –